FDA NDC Directory · JSON-LD · Markdown

TYRUKO

NDC 61314-543 · HUMAN PRESCRIPTION DRUG · INJECTION

Generic namenatalizumab-sztn
Labeler / ManufacturerSandoz Inc
Marketing categoryBiologic License Application · App BLA761322
Dosage form / routeINJECTION · INTRAVENOUS
Active ingredientsNATALIZUMAB (300 mg/15mL)
Marketing started20251117
Package count1

External sources

Source: openFDA. Public-domain (CC0).